Shilpa Medicare launches cancer drug at monthly therapy cost of Rs 6,440
Shilpa Medicare has launched the Indian branded generic of Dasatinib, an anti-cancer drug with a brand name Dasashil
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
J B Chemicals gets USFDA approval for Carbamazepine ER Tablets
The product is a generic version of Tegretol XR tablet in the same strength of Novartis Pharma
Granules India gets US FDA nod for overactive bladder treatment capsule
The product is generic version of Allergan Inc's Sanctura XR capsules in the same strength, it added
Pune’s Serum Institute to start making coronavirus vaccine that is under trial
Serum Institute of India will be manufacturing Oxford University's coronavirus vaccine in anticipation of clinical trials…
Herbal products from CIMAP may boost immunity to fight COVID-19 infection
It has decided to transfer the technology of its herbal products, CIM-Paushak and Herbal Cough Syrup to entrepreneurs and start-up…
Pharma among top domains of non-tech patents filed by India-domiciled cos in US in 2018-19: Nasscom…
The report is based on data extracted from Questel Orbit Patent Database as on January 31, 2020, with the support of Sagacious IP…
Making pharma greener with solar energy
Adoption of solar energy can be a game-changer for the pharma sector, however, only proper implementation will bring in the…
CDSCO anticipates low inventory of cardiac and anti-diabetic medicines, writes to all pharma…
The letter to all the associations from the CDSCO has also requested to take urgent, necessary action to ensure sufficient…
Oral polio vaccine can be effective against coronavirus: HIV co-discoverer
The vaccine has been documented to provide protection against a number of viral and bacterial infections other than poliomyelitis,…
Plans afoot to develop COVID-19 vaccine at the earliest: Dr Harsh Vardhan
Serum Institute of India is collaborating with Oxford University to make the Covid-19 vaccine
Union Health Minister Dr Harsh…